[Cancer Management and Research] Chinese researchers present a review of a rare cancer and strategies for managing the most common adverse effect of its treatment.
Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.
Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.
[OncoTargets and Therapy] A review of the role of radiation therapy and potential prognostic factors for selecting patients for more radical treatment.
Authors call for ongoing monitoring, treatment of those initially exposed.
[Cancer Management and Research] This network meta-analysis seeks to establish the optimal treatment in advanced nasopharyngeal carcinoma (NPC).
[Cancer Management and Research] This research examines the efficacy of mindfulness-based stress reduction (MBSR) on health-related quality of life, depression, and anxiety in patients with differentiated thyroid cancer receiving radioactive iodine therapy.
In a randomized phase 3 trial, researchers sought to determine if cetuximab-based chemoradiotherapy could be a less-toxic alternative to cisplatin-based chemoradiotherapy in patients with HPV-positive oropharyngeal cancer.
Researchers determined the 5-year overall and disease-free survival for patients with CSCC of the head and neck who received adjuvant radiation therapy.
Researchers assessed self-reports of chronic systemic symptoms experienced by head and neck cancer survivors at least 1 year posttreatment.
